Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Niedobitek

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
BMC Cancer|August 25, 2009
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinomaDominik Pretscher, Luitpold V Distel, Gerhard G Grabenbauer, et al.
Virology|March 12, 2002
Peripheral T-cell lymphoma in herpesvirus saimiri-infected tamarins: tumor cell lines reveal subgroup-specific differencesChristine Reiss, Gerald Niedobitek, Simon Hör, et al.
International Journal of Cancer|October 26, 2011
Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infectionMário Henrique M Barros, Gabriela Vera-Lozada, Fernando A Soares, et al.
The Journal of Pathology|May 14, 2004
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinomaNicole Heussinger, Maike Büttner, German Ott, et al.
Hematological Oncology|October 17, 2008
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphomaSabine Schreck, Daniela Friebel, Maike Buettner, et al.
Blood|August 3, 2006
Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growthStephanie Tobollik, Linda Meyer, Maike Buettner, et al.
Leukemia & Lymphoma|October 31, 2006
A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: a pilot studyJuergen Rech, Roland Repp, Dorit Rech, et al.
Hematological Oncology|June 15, 2018
Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphomaGabriela Vera-Lozada, Priscilla Segges, Claudio Gustavo Stefanoff, et al.
Annals of Neurology|September 10, 2011
Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymusMandy Meyer, Ann-Kathrin Höls, Britta Liersch, et al.
Scientific Reports|June 12, 2020
Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcomeLaura Werner, Johannes H Dreyer, David Hartmann, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
BMC Cancer|August 25, 2009
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinomaDominik Pretscher, Luitpold V Distel, Gerhard G Grabenbauer, et al.
Virology|March 12, 2002
Peripheral T-cell lymphoma in herpesvirus saimiri-infected tamarins: tumor cell lines reveal subgroup-specific differencesChristine Reiss, Gerald Niedobitek, Simon Hör, et al.
International Journal of Cancer|October 26, 2011
Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infectionMário Henrique M Barros, Gabriela Vera-Lozada, Fernando A Soares, et al.
The Journal of Pathology|May 14, 2004
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinomaNicole Heussinger, Maike Büttner, German Ott, et al.
Hematological Oncology|October 17, 2008
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphomaSabine Schreck, Daniela Friebel, Maike Buettner, et al.
Blood|August 3, 2006
Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growthStephanie Tobollik, Linda Meyer, Maike Buettner, et al.
Leukemia & Lymphoma|October 31, 2006
A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: a pilot studyJuergen Rech, Roland Repp, Dorit Rech, et al.
Hematological Oncology|June 15, 2018
Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphomaGabriela Vera-Lozada, Priscilla Segges, Claudio Gustavo Stefanoff, et al.
Annals of Neurology|September 10, 2011
Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymusMandy Meyer, Ann-Kathrin Höls, Britta Liersch, et al.
Scientific Reports|June 12, 2020
Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcomeLaura Werner, Johannes H Dreyer, David Hartmann, et al.
Pageof 7